Tenon Medical (TNON) Stock Price, News & Analysis

Company Overview

Tenon Medical, Inc. is a global medical technology platform specializing in the distribution, development and commercialization of innovative products across multiple clinical specialties. The company’s core business activities focus on advanced wound care, peripheral vascular surgery, urology and endoscopy. By partnering with leading device manufacturers and leveraging strategic acquisitions, Tenon Medical offers a comprehensive product portfolio aimed at improving patient outcomes and supporting health care providers.

The company’s diverse product line includes negative pressure wound therapy systems, advanced wound dressings, vascular stents and catheters, endoscopic accessories and urological devices. Tenon Medical combines these offerings with robust clinical support services, including training programs for physicians and nursing staff, to ensure proper device utilization and maximize therapeutic benefits. Its integrated approach spans pre-market development, regulatory support, sales force deployment and post-market surveillance.

Headquartered in Tampa, Florida, Tenon Medical serves customers in North America, Europe and select markets in Asia and Australia. The company operates distribution centers and service facilities that streamline supply chain logistics and provide rapid access to critical medical products. Through direct sales teams and partner networks, Tenon Medical supports hospitals, outpatient surgical centers and specialty clinics with tailored solutions that address local regulatory requirements and clinical practices.

Formed in 2021 through the combination of a special purpose acquisition company with a collection of established medical distribution businesses, Tenon Medical is led by a management team with deep experience in medtech and commercial operations. Under the leadership of Chief Executive Officer Patrick Treanor and Chief Financial Officer Adam Taber, the company continues to pursue strategic acquisitions and organic product launches to expand its footprint and enhance its service capabilities.

Key Stats

• Today's Range: $1.00 to $1.10
• 50-Day Range: $0.87 to $1.31
• 52-Week Range: $0.85 to $15.79
• Volume: 202,777 shs
• Average Volume: 2.52 million shs
• Market Capitalization: $7.74 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.67
• Consensus Rating: Buy

Tenon Medical Stock Analysis - MarketRank™

Tenon Medical scored higher than 37% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Tenon Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Tenon Medical has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Tenon Medical is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Tenon Medical is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Tenon Medical has a P/B Ratio of 1.44. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.21% of the float of Tenon Medical has been sold short.

Short Interest Ratio / Days to Cover

Tenon Medical has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Tenon Medical has recently increased by 387.23%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Tenon Medical does not currently pay a dividend.

Dividend Growth

Tenon Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.21% of the float of Tenon Medical has been sold short.

Short Interest Ratio / Days to Cover

Tenon Medical has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Tenon Medical has recently increased by 387.23%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.63

News Sentiment

Tenon Medical has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Tenon Medical this week, compared to 0 articles on an average week.

Search Interest

Only 1 people have searched for TNON on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

2 people have added Tenon Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Tenon Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.33% of the stock of Tenon Medical is held by insiders.

Percentage Held by Institutions

Only 22.74% of the stock of Tenon Medical is held by institutions.

TNON Stock Analysis - Frequently Asked Questions

How have TNON shares performed this year?

Tenon Medical's stock was trading at $1.88 on January 1st, 2025. Since then, TNON shares have decreased by 45.7% and is now trading at $1.02.

How were Tenon Medical's earnings last quarter?

Tenon Medical, Inc. (NASDAQ:TNON) released its earnings results on Tuesday, May, 13th. The company reported ($1.01) EPS for the quarter, beating the consensus estimate of ($1.06) by $0.05. The firm had revenue of $0.73 million for the quarter, compared to analysts' expectations of $0.76 million. Tenon Medical had a negative trailing twelve-month return on equity of 558.92% and a negative net margin of 417.57%.
Read the conference call transcript.

When did Tenon Medical IPO?

Tenon Medical (TNON) raised $16 million in an IPO on Wednesday, April 27th 2022. The company issued 3,200,000 shares at a price of $4.50-$5.50 per share.

How do I buy shares of Tenon Medical?

Shares of TNON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Tenon Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tenon Medical investors own include Ardelyx (ARDX), Broadcom (AVGO), CrowdStrike (CRWD), First Financial Bankshares (FFIN), Eli Lilly and Company (LLY) and Meta Platforms (META).

Company Calendar

• Last Earnings: 5/13/2025
• Today: 7/13/2025
• Next Earnings (Estimated): 8/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:TNON
• CIK: 1560293
• Web: www.tenonmed.com
• Phone: 408-649-5760
• Fax: N/A
• Employees: 8
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Tenon Medical: $4.67
• High Price Target: $8.00
• Low Price Target: $3.00
• Potential Upside/Downside: +357.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($27.23)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$13.67 million
• Net Margins: -417.57%
• Pretax Margin: -417.57%
• Return on Equity: -558.92%
• Return on Assets: -129.73%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.46
• Quick Ratio: 5.19

Sales & Book Value

• Annual Sales: $3.28 million
• Price / Sales: 2.36
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.71 per share
• Price / Book: 1.44

Miscellaneous

• Outstanding Shares: 7,590,000
• Free Float: 7,565,000
• Market Cap: $7.74 million
• Optionable: Not Optionable
• Beta: 1.22